Preeclampsia and Risk of Developing Subsequent Diabetes

REFERENCES

• Hauth JC, Ewell MG, Levine RJ, Esterlitz JR, Sibai B, Curet LB, . Pregnancy outcomes in healthy nulliparas who developed hypertension. Calcium for Preeclampsia Prevention Study Group. Obstet Gynecol 2000; 95(1):24–28. Jan
   PubMed Web of Science ®Google Scholar
• Cunningham FG, Gant NF, Leveno KJ, Gilstrap LCI, Hauth JC, Wenstrom KD. Hypertensive disorders in pregnancy. Williams Obstetrics. 21st Edition ed. New York: McGraw-Hill; 2001. p. 567–618.
   Google Scholar
• D'Anna R, Baviera G, Corrado F, Giordano D, De Vivo A, Nicocia G, . Adiponectin and insulin resistance in early- and late-onset pre-eclampsia. BJOG 2006; 113(11):1264–1269. Nov
   PubMed Web of Science ®Google Scholar
• Kaaja R, Laivuori H, Laakso M, Tikkanen MJ, Ylikorkala O. Evidence of a state of increased insulin resistance in preeclampsia. Metabolism 1999; 48:892–896.
   PubMed Web of Science ®Google Scholar
• Emery SP, Levine RJ, Qian C, Ewell MG, England LJ, Yu KF, . Twenty-four‐hour urine insulin as a measure of hyperinsulinaemia/insulin resistance before onset of pre-eclampsia and gestational hypertension. Bjog 2005; 112(11):1479–1485. Nov
   PubMed Web of Science ®Google Scholar
• Parretti E, Lapolla A, Dalfra M, Pacini G, Mari A, Cioni R, . Preeclampsia in lean normotensive normotolerant pregnant women can be predicted by simple insulin sensitivity indexes. Hypertension 2006; 47(3):449–453. Mar
   PubMed Web of Science ®Google Scholar
• Hubel CA, McLaughlin MK, Evans RW, Hauth BA, Sims CJ, Roberts JM. Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease with 48 hours post partum. Am J Obstet Gynecol 1996; 174:975–982.
   PubMed Web of Science ®Google Scholar
• Sacks G, Studena K, Sargent I, Redman C. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol 1998; 179:80–86.
   PubMed Web of Science ®Google Scholar
• Williams MA, Farrand A, Mittendorf R, Sorensen TK, Zingheim RW, O'Reilly GC, . Maternal second trimester serum tumor necrosis factor-a soluble receptor p55 (sTNFp55) and subsequent risk of preeclampsia. Am J Epidemiol 1999; 149:323–329.
   PubMed Web of Science ®Google Scholar
• Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, . Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350(7):672–683. Feb 12
   PubMed Web of Science ®Google Scholar
• Bosio P, O'Herlihy R, Conroy P, McKenna P. Maternal central hemodynamics in hypertensive disorders of pregnancy: a longitudinal study. Am J Obstet Gynecol 1998; 178:S6.
   Google Scholar
• Easterling T, Benedetti T, Schmucker B, Millard S. Maternal hemodynamics in normal and preeclamptic pregnancies. A longitudinal study. Obstet Gynecol 1990; 76:1061–1069.
   PubMed Web of Science ®Google Scholar
• Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, . Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112(17):2735–2752. Oct 25
   PubMed Web of Science ®Google Scholar
• Wolf M, Hubel CA, Lam C, Sampson M, Ecker JL, Ness RB, . Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance. J Clin Endocrinol Metab 2004; 89(12):6239–6243. Dec
   PubMed Web of Science ®Google Scholar
• Laivuori H, Tikkanen MJ, Ylikorkala O. Hyperinsulinemia 17 years after preeclamptic first pregnancy. J Clin Endocrinol Metab 1996; 81:2908–2911.
   PubMed Web of Science ®Google Scholar
• Forest JC, Girouard J, Masse J, Moutquin JM, Kharfi A, Ness RB, . Early occurrence of metabolic syndrome after hypertension in pregnancy. Obstet Gynecol 2005; 105(6):1373–1380. Jun
   PubMed Web of Science ®Google Scholar
• Fuh M, Yin C, Pei D, Sheu W, Jeng C, Ida Chen Y, . Resistance to insulin-mediated glucose uptake and hyperinsulinemia in women who had preeclampsia during pregnancy. Am J Hypertens 1995; 8:768–771.
   PubMed Web of Science ®Google Scholar
• Chesley L, Annitto J, Cosgrove R. The remote prognosis of eclamptic women. Am J Obstet Gynecol 1976; 124:446–459.
   PubMed Web of Science ®Google Scholar
• Bryans CIJr.. The remote prognosis in toxemia of pregnancy. Clin Obstet Gynecol 1966; 9(4):973–990. Dec
   PubMedGoogle Scholar
• Chambers JC, Fusi L, Malik IS, Haskard DO, De Swiet M, Kooner JS. Association of maternal endothelial dysfunction with preeclampsia. JAMA 2001; 28:1607–1612.
   Google Scholar
• Adams E, MacGillivray I. Long-term effect of pre-eclampsia on blood-pressure. Lancet 1961; 32:1373–1375.
   Google Scholar
• Sibai B, El-Nazer A, Gonzalez-Ruiz A. Severe preeclampsia-eclampsia in young primigravid women: subsequent pregnancy outcome and remote prognosis. Am J Obstet Gynecol 1986; 155:1011–1016.
   PubMed Web of Science ®Google Scholar
• Wilson BJ, Watson MS, Prescott GJ, Sunderland S, Campbell DM, Hannaford P, . Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. BMJ 2003; 326(7394):845. Apr 19
   PubMed Web of Science ®Google Scholar
• Jonsdottir L, Arngrimsson R, Geirsson R, Sigvaldason H, Sigfusson N. Death rates from ischemic heart disease in women with a history of hypertension in pregnancy. Acta Obstet Gynecol Scand 1995; 74:772–776.
   PubMed Web of Science ®Google Scholar
• Hannaford P, Ferry S, Hirsch S. Cardiovascular sequalae of toxaemia of pregnancy. Heart 1997; 77:154–158.
   PubMed Web of Science ®Google Scholar
• Smith GC, Pell JP, Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet 2001; 357(9273):2002–2006. Jun 23
   PubMed Web of Science ®Google Scholar
• Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. Bmj 2001; 323(7323):1213–1217. Nov 24
   PubMed Web of Science ®Google Scholar
• Kestenbaum B, Seliger SL, Easterling TR, Gillen DL, Critchlow CW, Stehman-Breen CO, . Cardiovascular and thromboembolic events following hypertensive pregnancy. Am J Kidney Dis 2003; 42(5):982–989. Nov
   PubMed Web of Science ®Google Scholar
• Funai EF, Friedlander Y, Paltiel O, Tiram E, Xue X, Deutsch L, . Long-term mortality after preeclampsia. Epidemiology 2005; 16(2):206–215. Mar
   PubMed Web of Science ®Google Scholar
• Libby G, Murphy DJ, McEwan NF, Greene SA, Forsyth JS, Chien PW, . Pre‐eclampsia and the later development of type 2 diabetes in mothers and their children: an intergenerational study from the Walker cohort. Diabetologia 2007; 50(3):523–530. Mar
   PubMed Web of Science ®Google Scholar
• Callaway LK, Lawlor DA, O'Callaghan M, Williams GM, Najman JM, McIntyre HD. Diabetes mellitus in the 21 years after a pregnancy that was complicated by hypertension: findings from a prospective cohort study. Amer J Obstetrics Gynecol 2007; 197(5):492–7. Nov
   PubMed Web of Science ®Google Scholar
• Joffe GM, Esterlitz JR, Levine RJ, Clemens JD, Ewell MG, Sibai BM, . The relationship between abnormal glucose tolerance and hypertensive disorders of pregnancy in healthy nulliparous women. Calcium for Preeclampsia Prevention (CPEP) Study Group. Am J Obstet Gynecol 1998; 179(4):1032–1037. Oct
   PubMed Web of Science ®Google Scholar
• Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes. Diabetes Care 2002; 25:1862–1868.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Screening for type 2 diabetes. Diabetes Care 2004; 27(Suppl 1):S11–14.
   Web of Science ®Google Scholar
• Newton KM, La Croix AZ, Heckbert SR, Abraham L, McCulloch D, Barlow W. Estrogen therapy and risk of cardiovascular events among women wtih type 2 diabetes. Diabetes Care 2003; 26:2810–2816.
   PubMed Web of Science ®Google Scholar
• Stone JL, Lockwood CJ, Berkowitz GS, Alvarez M, Lapinski R, Berkowitz RL. Risk factors for severe preeclampsia. Obstet Gynecol 1994; 83(3):357–361. Mar
   PubMed Web of Science ®Google Scholar
• Carr DB, Utzschneider KM, Hull RL, Kodama K, Retzlaff BM, Brunzell JD, . Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 2004; 53(8):2087–2094. Aug
   PubMed Web of Science ®Google Scholar
• Hayashi T, Boyko EJ, Leonetti DL, McNeely MJ, Newell-Morris L, Kahn SE, . Visceral adiposity and the risk of impaired glucose tolerance: a prospective study among Japanese Americans. Diabetes Care 2003; 26:650–655.
   PubMed Web of Science ®Google Scholar
• Boyko EJ, Fujimoto WY, Leonetti DL, Newell-Morris L. Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans. Diabetes Care 2000; 23:465–471.
   PubMed Web of Science ®Google Scholar
• Fujimoto WY, Bergstrom RW, Boyko EJ, Chen KW, Leonetti DL, Newell-Morris L, . Visceral adiposity and incident coronary heart disease in Japanese-American men. The 10-year follow-up results of the Seattle Japanese-American Community Diabetes Study. Diabetes Care 1999; 22:1808–1812.
   PubMed Web of Science ®Google Scholar
• van Harmelen V, Dicker A, Ryden M, Hauner H, Lonnqvist F, Naslund E, . Increased lipolysis and decreased leptin production by human omental as compared with subcutaneous preadipocytes. Diabetes 2002; 51:2029–2036.
   PubMed Web of Science ®Google Scholar
• Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, . Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003; 46:459–469.
   PubMed Web of Science ®Google Scholar
• Katsuki A, Sumida Y, Murashima S, Murata K, Takarada Y, Ito K, . Serum levels of tumor necrosis factor-a are increased in obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1998; 83:859–862.
   PubMed Web of Science ®Google Scholar
• Alessi MC, Peiretti F, Morange P, Henry M, Nalbone G, Juhan-Vague I. Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes 1997; 46:860–867.
   PubMed Web of Science ®Google Scholar
• Reith A, Booth N, Moore N, Cruickshank D, Bennett B. Plasminogen activator inhibitors (PAI-1 and PAI-2) in normal pregnancies, preeclampsia, and hydatidiform mole. Br J Obstet Gynaecol 1993; 100:370–374.
   PubMedGoogle Scholar
• Kenny SJ, Aubert R, Geiss LS. Prevalence and incidence of non-insulin dependent diabetes. Diabetes in America. 2nd ed: NIH NIDDK; 1995. p. 47–67.
   Google Scholar
• Lydon-Rochelle MT, Holt VL, Cardenas V, Nelson JC, Easterling TR, Gardella C, . The reporting of pre-existing maternal medical conditions and complications of pregnancy on birth certificates and in hospital discharge data. Am J Obstet Gynecol 2005; 193(1):125–134. Jul
   PubMed Web of Science ®Google Scholar
• Frederick IO, Rudra CB, Miller RS, Foster JC, Williams MA. Adult weight change, weight cycling, and prepregnancy obesity in relation to risk of preeclampsia. Epidemiology 2006; 17(4):428–434. Jul
   PubMed Web of Science ®Google Scholar
• Ness RB, Markovic N, Bass D, Harger G, Roberts JM. Family history of hypertension, heart disease, and stroke among women who develop hypertension in pregnancy. Obstet Gynecol 2003; 102(6):1366–1371. Dec
   PubMed Web of Science ®Google Scholar
• Qiu C, Williams MA, Leisenring WM, Sorensen TK, Frederick IO, Dempsey JC, . Family history of hypertension and type 2 diabetes in relation to preeclampsia risk. Hypertension 2003; 41(3):408–413. Mar
   PubMed Web of Science ®Google Scholar
• Chiasson JL. Acarbose for the prevention of diabetes, hypertension, and cardiovascular disease in subjects with impaired glucose tolerance: the Study to Prevent Non-Insulin-Dependent Diabetes Mellitus (STOP-NIDDM). Trial. Endocr Pract 2006; 1(12 Suppl):25–30. Jan–Feb
   Google Scholar
• Gerstein HC, Yusuf S, Bosch J, Pogue J, Sheridan P, Dinccag N, . Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet 2006; 368(9541):1096–1105. Sep 23
   PubMed Web of Science ®Google Scholar
• Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, . Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346:393–403.
   PubMed Web of Science ®Google Scholar